期刊文献+

接种不同剂量国产重组酵母乙肝疫苗效果分析 被引量:13

An Analysis of the Effect of Domestic Recombinant Yeast Heptatitis B Vaccine of Different Doses
下载PDF
导出
摘要 目的了解不同剂量乙肝疫苗接种的效果,对乙肝疫苗合理接种提供依据。方法将近年有乙肝疫苗全程接种史但未产生抗-HBs的学生360人,以及近年无接种史且抗-HBs阴性者469人,将两类人群各分成3组,分别进行5μg、10μg、20μg国产重组酵母乙肝疫苗的接种,全程接种后1个月,观察各组学生抗-HBs阳转情况。结果无接种史者给予3种不同剂量乙肝疫苗的全程接种,抗-HBs阳转率达85.26%、87.82%、88.54%,差异无统计学意义(P>0.05)。有接种史未产生抗体组,接种5μg,10μg,20μg 3种疫苗剂量,抗体阳转率分别为34.17%、50.83%、61.67%,10μg组和20μg组均高于5μg组,差异有统计学意义(P<0.01),10μg组和20μg组间差异无统计学意义(P>0.05)。结论对于全程接种未产生抗-HBs者,随着剂量的增加抗-HBs的阳转率增高,建议给予10μg或20μg剂量疫苗全程再接种,一般人群给予5μg剂量疫苗即可。 Objective To understand the results of different doses of hepatitis B vaccine in order provide references for rational vaccination.Method We divided into 3 groups 360 students who had been vaccinated with hepatitis B vaccine without HBsAb and 469 students who weren't vaccinated with negative for HBsAb.They were vaccinated 5 μg,10 μg,20 μg respectively.They were under close inspection to observe the situation of turning positive for an HBsAb.Results The students not vaccinate before have been vaccinated 3 different doses,and positive rates of HBsAb were 85.26%,87.82%,88.54% respectively,which is of no statistical significance(P0.05).The students vaccinated with hepatitis B vaccine without HBsAb have been vaccinated 3 different doses,and positive rates of HBsAb were 34.17%,50.83%,61.67% respectively,which is of statistical significance(P0.01).Conclusion To the cases with immune tolerance,the positive rates of HBsAb rise with the increasing of the doses.So 10 μg is suggested for revaccination.And 5 μg is suitable for common cases.
出处 《保健医学研究与实践》 2011年第1期46-47,49,共3页 Health Medicine Research and Practice
关键词 高校 乙肝疫苗 接种 效果 College Hepatitis B vaccine Vaccinate Effect
  • 相关文献

参考文献8

二级参考文献23

  • 1Young MD,Gooch WM 3rd,Zuckerman AJ,et al.Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination[J].Med Virol,2001,64:290-298.
  • 2Keating GM,Noble S.Recombinant hepatitis B vaccine (Engerix-B):a review of its immunogenicity and protective efficacy against hepatitis B[J].Drugs,2003,63:1021-1051.
  • 3Stephenne J.Recombinant versus plasma-derived hepatitis B vaccines:issues of safety,immunogenicity and cost-effectiveness vaccines[A].1998,6:299-303.
  • 4Keating GM.Noble S.Recombinant hepatitis B vaccine (Engerix -B) areview of its immunogenicity and protective efficacy against hepatitis B[Z].Drugs.2003,63:1021-1051.
  • 5Authority CDC.New recommended schedule for hepatitis B immunization.JAMA 2002,13(6):707.
  • 6Van DP,Vorster SA.Hepatitis B control in Euripe by universal vaccination programs;the situation in 2001.J Med Viol,2002,67 (3):433.
  • 7刘蓬勃,徐慧文,李辉,王学良,乌正赉,王小峰,张孔来,曾宪嘉,潘利.乙型肝炎疫苗接种无、弱应答与人类白细胞抗原的关系[J].中华预防医学杂志,1998,32(2):126-127. 被引量:16
  • 8靳维声,邢玉兰,陈铁珊,张淑先,张晓红.重组酵母乙肝疫苗免疫效果研究[J].中华微生物学和免疫学杂志,1998,18(4):324-326. 被引量:42
  • 9杜克洪.关于基因工程乙型肝炎疫苗应用前景的探讨[J].中华流行病学杂志,1998,19(5):310-311. 被引量:26
  • 10胡蓉,曹务春,张习坦.部队乙型肝炎疫苗预防接种的成本效果分析[J].中华流行病学杂志,2001,22(2):142-145. 被引量:27

共引文献55

同被引文献146

引证文献13

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部